<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref151">
 <mixed-citation publication-type="journal" id="cit151">
  <name>
   <surname>Zilker</surname>
   <given-names>C.</given-names>
  </name>; 
  <name>
   <surname>Kozlova</surname>
   <given-names>D.</given-names>
  </name>; 
  <name>
   <surname>Sokolova</surname>
   <given-names>V.</given-names>
  </name>; 
  <name>
   <surname>Yan</surname>
   <given-names>H.</given-names>
  </name>; 
  <name>
   <surname>Epple</surname>
   <given-names>M.</given-names>
  </name>; 
  <name>
   <surname>Überla</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Temchura</surname>
   <given-names>V.</given-names>
  </name>
  <article-title>Nanoparticle-Based B-Cell Targeting Vaccines: Tailoring of Humoral Immune Responses by Functionalization with Different TLR-Ligands</article-title>. 
  <source>Nanomedicine</source>
  <year>2017</year>, 
  <volume>13</volume>, 
  <fpage>173</fpage>–
  <lpage>182</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.nano.2016.08.028</pub-id>.
  <pub-id pub-id-type="pmid">27593489</pub-id>
 </mixed-citation>
</ref>
